REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Legochem Biosciences Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Legochem Biosciences Inc. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

LegoChem Biosciences, Inc is a new drug development company. The company operates in the pharmaceutical industry, focusing on medical equipment, professional pharmaceutical business, and ADC therapeutic development. LegoChem Biosciences develops pipelines, including ADC, immuno-cancer, antibiotics, and anti-fiber. The company targets the global pharmaceutical industry and is known for its ADC development capacity.

Headquarters
8-26 Munpyeongseo-Ro, Daedeok-Gu, Gwangyeok-Si
Daejeon; Daejeon;

Contact Details: Purchase the Legochem Biosciences Inc. report to view the information.

Website: http://www.legochembio.com

Basic Information
Total Employees:
Purchase the Legochem Biosciences Inc. report to view the information.
Outstanding Shares:
Purchase the Legochem Biosciences Inc. report to view the information.
Registered Capital:
Purchase the Legochem Biosciences Inc. report to view the information.
Financial Auditors:
Purchase the Legochem Biosciences Inc. report to view the information.
Incorporation Date:
May 02, 2006
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
17.24%
Purchase this report to view the information.
6.06%
Purchase this report to view the information.
3.03%
Purchase this report to view the information.
2.86%
Purchase this report to view the information.
0.21%
Subsidiaries
Geom Therapeutics
10.04%
(주)인투셀
4.36%
브릿지바이오
2.33%
Company Performance
Financial values in the chart are available after Legochem Biosciences Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
4.43%▲
Total operating revenue
4.11%▲
Operating profit (EBIT)
-118.55%▼
EBITDA
-132.54%▼
Net Profit (Loss) for the Period
-193.77%▼
Total assets
-27.16%▼
Total equity
-32.97%▼
Operating Profit Margin (ROS)
-115.7%▼
Net Profit Margin
-148.62%▼
Return on Equity (ROE)
-27.27%▼
Debt to Equity Ratio
2.4%▲
Quick Ratio
-11.26%▼
Cash Ratio
-7.47%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo